153 related articles for article (PubMed ID: 23314482)
1. Formation of an N-formylkynurenine-derived fluorophore and its use for measuring indoleamine 2,3-dioxygenase 1 activity.
Tomek P; Palmer BD; Flanagan JU; Fung SP; Bridewell DJ; Jamie JF; Ching LM
Anal Bioanal Chem; 2013 Mar; 405(8):2515-24. PubMed ID: 23314482
[TBL] [Abstract][Full Text] [Related]
2. High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
Seegers N; van Doornmalen AM; Uitdehaag JC; de Man J; Buijsman RC; Zaman GJ
J Biomol Screen; 2014 Oct; 19(9):1266-74. PubMed ID: 24870017
[TBL] [Abstract][Full Text] [Related]
3. Nitrobenzofurazan derivatives of N'-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1.
Paul S; Roy A; Deka SJ; Panda S; Trivedi V; Manna D
Eur J Med Chem; 2016 Oct; 121():364-375. PubMed ID: 27267006
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
[TBL] [Abstract][Full Text] [Related]
5. Reliable chromatographic assay for measuring of indoleamine 2,3-dioxygenase 1 (IDO1) activity in human cancer cells.
Sadok I; Rachwał K; Jonik I; Staniszewska M
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):581-592. PubMed ID: 33541164
[TBL] [Abstract][Full Text] [Related]
6. Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
Tomek P; Palmer BD; Flanagan JU; Sun C; Raven EL; Ching LM
Eur J Med Chem; 2017 Jan; 126():983-996. PubMed ID: 28011425
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Röhrig UF; Majjigapu SR; Vogel P; Zoete V; Michielin O
J Med Chem; 2015 Dec; 58(24):9421-37. PubMed ID: 25970480
[TBL] [Abstract][Full Text] [Related]
8. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
[TBL] [Abstract][Full Text] [Related]
9. Cell-Based Identification of New IDO1 Modulator Chemotypes.
Hennes E; Lampe P; Dötsch L; Bruning N; Pulvermacher LM; Sievers S; Ziegler S; Waldmann H
Angew Chem Int Ed Engl; 2021 Apr; 60(18):9869-9874. PubMed ID: 33565680
[TBL] [Abstract][Full Text] [Related]
10. Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening.
Guo W; Yao S; Sun P; Yang TB; Tang CP; Zheng MY; Ye Y; Meng LH
Acta Pharmacol Sin; 2020 Mar; 41(3):423-431. PubMed ID: 31197246
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
Sari S; Tomek P; Leung E; Reynisson J
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096
[TBL] [Abstract][Full Text] [Related]
12. Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form.
Nelp MT; Kates PA; Hunt JT; Newitt JA; Balog A; Maley D; Zhu X; Abell L; Allentoff A; Borzilleri R; Lewis HA; Lin Z; Seitz SP; Yan C; Groves JT
Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3249-3254. PubMed ID: 29531094
[TBL] [Abstract][Full Text] [Related]
13. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
Gao D; Li Y
Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel sulfonamide chromone-oxime derivatives as potent indoleamine 2,3-dioxygenase 1 inhibitors.
Wang K; Song LH; Liang QL; Zhang Y; Ma XL; Wang Q; Zhang HY; Jiang CN; Wei JH; Huang RZ
Eur J Med Chem; 2023 Jun; 254():115349. PubMed ID: 37060754
[TBL] [Abstract][Full Text] [Related]
15. A fluorescence-based assay for indoleamine 2,3-dioxygenase.
Matin A; Streete IM; Jamie IM; Truscott RJ; Jamie JF
Anal Biochem; 2006 Feb; 349(1):96-102. PubMed ID: 16321356
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel IDO1 inhibitors via structure-based virtual screening and biological assays.
Ge H; Mao L; Zhao J; Wang Y; Shi D; Yang X; Wang X; Liu H; Yao X
J Comput Aided Mol Des; 2021 May; 35(5):679-694. PubMed ID: 33905074
[TBL] [Abstract][Full Text] [Related]
17. Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay.
Capochiani de Iudicibus R; Tomek P; Palmer BD; Tijono SM; Flanagan JU; Ching LM
Bioorg Med Chem; 2021 Jun; 39():116160. PubMed ID: 33901770
[TBL] [Abstract][Full Text] [Related]
18. Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3.
Huang R; Jing X; Huang X; Pan Y; Fang Y; Liang G; Liao Z; Wang H; Chen Z; Zhang Y
J Med Chem; 2020 Feb; 63(4):1544-1563. PubMed ID: 31999451
[TBL] [Abstract][Full Text] [Related]
19. Fragment-based approach to identify IDO1 inhibitor building blocks.
Coletti A; Camponeschi F; Albini E; Greco FA; Maione V; Custodi C; Ianni F; Grohmann U; Orabona C; Cantini F; Macchiarulo A
Eur J Med Chem; 2017 Dec; 141():169-177. PubMed ID: 29031064
[TBL] [Abstract][Full Text] [Related]
20. Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors.
Meininger D; Zalameda L; Liu Y; Stepan LP; Borges L; McCarter JD; Sutherland CL
Biochim Biophys Acta; 2011 Dec; 1814(12):1947-54. PubMed ID: 21835273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
